Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Dziadziuszko Follows in Footsteps of Thoracic Oncology Icon, Receives Award in...
lungcanc
2017 ASCO Annual Meeting
lungcanc
FDA Corner – Interview with Commander Jason Humbert
lungcanc
European Perspective on Molecular Testing
lungcanc
The CRISPR-Cas9 Toolkit: Moving From Bench to Bedside
lungcanc
An Argument for a Large-Scale Low-Dose CT Lung Cancer Screening Trial...
lungcanc
Lung Cancer Screening Is Cost Effective
lungcanc
Interview with Bruce Johnson, MD, 2017-2018 ASCO President
lungcanc
IASLC International Mentorship Program Boosts Early Careers, Fosters International Collaboration
lungcanc
NCI Formulary Holds Promise to Speed Clinical Trials
lungcanc
1
...
37
38
39
...
53
Page 38 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
